United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$97Mraised across 5 rounds since 2007, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Alta Partners
Frazier Healthcare PartnersReported by calistogapharma.comSEC filing: $19M sold, first sale Jun 2010
From a historical funding recordSEC filing: $15M sold, first sale May 2009
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Mar 2009
From a historical funding record
Reported by calistogapharma.com
From the SEC filings it signed: 5 on the team.
On the board, as filediEdward Michael HurwitzJames Michael TopperRichard Michael LinRobert Lee Douglas
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alta PartnersThree Arch PartnersFrazier Healthcare PartnersAmgenFrazier Technology VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Calistoga Pharmaceuticals's investors include Alta Partners, Three Arch Partners, Frazier Healthcare Partners, Amgen and Frazier Technology Ventures, and 3 more on record.
Calistoga Pharmaceuticals has raised $97M across 5 rounds since 2007.
Calistoga Pharmaceuticals's most recent round was a Series C of $40M in Jun 2010.
Its most recent round, $40M in Jun 2010, is also its largest on record.
Calistoga Pharmaceuticals's first round on record, in Mar 2007, was backed by Alta Partners, Frazier Healthcare Partners and Three Arch Partners and 1 others.
Calistoga Pharmaceuticals's latest named round is a Series C, in Jun 2010.
Calistoga Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
